Insulin trials for Obesity

All Insulin trials · All Obesity trials

Phase breakdown

Recruiting trials studying Insulin for Obesity

• Efficacy and Safety of Empagliflozin or Semaglutide in Overweight/Obese Patients With Type 1 Diabetes
  NCT06762314 · Phase: Phase 2 · Ages: 18 Years to 65 Years · Sex: All (male and female) · 1 location
• Insulin Sensitivity After Breast Cancer
  NCT05010356 · Phase: Not applicable (e.g. observational or device study) · Ages: 20 Years to 45 Years · Sex: Female · 1 location
• Regional Lipolysis Insulin Regulation
  NCT06392854 · Phase: Early Phase 1 · Ages: 18 Years to 65 Years · Sex: All (male and female) · 1 location

Common questions

How many trials study Insulin for Obesity?

3 recruiting trials.

Is this list complete?

No. For the full record, search ClinicalTrials.gov.